340 related articles for article (PubMed ID: 37446161)
1. Receptor for the Advanced Glycation End Products (
Gutowska K; Czajkowski K; Kuryłowicz A
Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446161
[TBL] [Abstract][Full Text] [Related]
2. Glycation & the RAGE axis: targeting signal transduction through DIAPH1.
Shekhtman A; Ramasamy R; Schmidt AM
Expert Rev Proteomics; 2017 Feb; 14(2):147-156. PubMed ID: 27967251
[TBL] [Abstract][Full Text] [Related]
3. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
4. RAGE signalling in obesity and diabetes: focus on the adipose tissue macrophage.
Feng Z; Zhu L; Wu J
Adipocyte; 2020 Dec; 9(1):563-566. PubMed ID: 32892690
[TBL] [Abstract][Full Text] [Related]
5. The RAGE/DIAPH1 axis: mediator of obesity and proposed biomarker of human cardiometabolic disease.
Arivazhagan L; Popp CJ; Ruiz HH; Wilson RA; Manigrasso MB; Shekhtman A; Ramasamy R; Sevick MA; Schmidt AM
Cardiovasc Res; 2024 Feb; 119(18):2813-2824. PubMed ID: 36448548
[TBL] [Abstract][Full Text] [Related]
6. Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
Dozio E; Vianello E; Bandera F; Longhi E; Brizzola S; Nebuloni M; Corsi Romanelli MM
Mediators Inflamm; 2019; 2019():2712376. PubMed ID: 30944546
[TBL] [Abstract][Full Text] [Related]
7. Nε-(carboxymethyl)lysine-receptor for advanced glycation end product axis is a key modulator of obesity-induced dysregulation of adipokine expression and insulin resistance.
Gaens KH; Goossens GH; Niessen PM; van Greevenbroek MM; van der Kallen CJ; Niessen HW; Rensen SS; Buurman WA; Greve JW; Blaak EE; van Zandvoort MA; Bierhaus A; Stehouwer CD; Schalkwijk CG
Arterioscler Thromb Vasc Biol; 2014 Jun; 34(6):1199-208. PubMed ID: 24723555
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the Receptor for Advanced Glycation End Products (RAGE) in high fat-high sugar diet-induced anhedonia in rats.
Carr KD; Weiner SP; Vasquez C; Schmidt AM
Physiol Behav; 2023 Nov; 271():114337. PubMed ID: 37625475
[TBL] [Abstract][Full Text] [Related]
9. Relationship of Advanced Glycation End Products With Cardiovascular Disease in Menopausal Women.
Pertynska-Marczewska M; Merhi Z
Reprod Sci; 2015 Jul; 22(7):774-82. PubMed ID: 25228634
[TBL] [Abstract][Full Text] [Related]
10. Evidence that methylglyoxal and receptor for advanced glycation end products are implicated in bladder dysfunction of obese diabetic
Oliveira AL; Medeiros ML; Ghezzi AC; Dos Santos GA; Mello GC; Mónica FZ; Antunes E
Am J Physiol Renal Physiol; 2023 Oct; 325(4):F436-F447. PubMed ID: 37560771
[TBL] [Abstract][Full Text] [Related]
11. Implication of advanced glycation end products (Ages) and their receptor (Rage) on myocardial contractile and mitochondrial functions.
Neviere R; Yu Y; Wang L; Tessier F; Boulanger E
Glycoconj J; 2016 Aug; 33(4):607-17. PubMed ID: 27277623
[TBL] [Abstract][Full Text] [Related]
12. DNA aptamer raised against receptor for advanced glycation end products suppresses renal tubular damage and improves insulin resistance in diabetic mice.
Sotokawauchi A; Matsui T; Higashimoto Y; Nishino Y; Koga Y; Yagi M; Yamagishi SI
Diab Vasc Dis Res; 2021; 18(1):1479164121990533. PubMed ID: 33535822
[TBL] [Abstract][Full Text] [Related]
13. Advanced Glycation End Products (AGEs), Glutathione and Breast Cancer: Factors, Mechanism and Therapeutic Interventions.
Sharma AK; Sharma VR; Gupta GK; Ashraf GM; Kamal MA
Curr Drug Metab; 2019; 20(1):65-71. PubMed ID: 30207227
[TBL] [Abstract][Full Text] [Related]
14. Age-related accumulation of advanced glycation end-products-albumin, S100β, and the expressions of advanced glycation end product receptor differ in visceral and subcutaneous fat.
Son KH; Son M; Ahn H; Oh S; Yum Y; Choi CH; Park KY; Byun K
Biochem Biophys Res Commun; 2016 Aug; 477(2):271-6. PubMed ID: 27301641
[TBL] [Abstract][Full Text] [Related]
15. Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.
Yue Q; Song Y; Liu Z; Zhang L; Yang L; Li J
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956875
[TBL] [Abstract][Full Text] [Related]
16. Fructose causes endothelial cell damage via activation of advanced glycation end products-receptor system.
Sotokawauchi A; Matsui T; Higashimoto Y; Yamagishi SI
Diab Vasc Dis Res; 2019 Nov; 16(6):556-561. PubMed ID: 31375034
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end-products regulate extracellular matrix-adipocyte metabolic crosstalk in diabetes.
Strieder-Barboza C; Baker NA; Flesher CG; Karmakar M; Neeley CK; Polsinelli D; Dimick JB; Finks JF; Ghaferi AA; Varban OA; Lumeng CN; O'Rourke RW
Sci Rep; 2019 Dec; 9(1):19748. PubMed ID: 31875018
[TBL] [Abstract][Full Text] [Related]
18. Aldose reductase (AKR1B3) regulates the accumulation of advanced glycosylation end products (AGEs) and the expression of AGE receptor (RAGE).
Baba SP; Hellmann J; Srivastava S; Bhatnagar A
Chem Biol Interact; 2011 May; 191(1-3):357-63. PubMed ID: 21276777
[TBL] [Abstract][Full Text] [Related]
19. RAGE displays sex-specific differences in obesity-induced adipose tissue insulin resistance.
Du Z; Wu J; Feng Z; Ma X; Zhang T; Shu X; Xu J; Wang L; Luo M; Wu J
Biol Sex Differ; 2022 Nov; 13(1):65. PubMed ID: 36348465
[TBL] [Abstract][Full Text] [Related]
20. Fructose-induced AGEs-RAGE signaling in skeletal muscle contributes to impairment of glucose homeostasis.
Rai AK; Jaiswal N; Maurya CK; Sharma A; Ahmad I; Ahmad S; Gupta AP; Gayen JR; Tamrakar AK
J Nutr Biochem; 2019 Sep; 71():35-44. PubMed ID: 31272030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
